Ernest Asante‐Appiah

<i>In Vitro</i>Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor

Ming‐Tain Lai, Meizhen Feng, Jean‐Pierre Falgueyret et al. · Antimicrobial Agents and Chemotherapy · 2013 · 140 citations · Full text

Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers

I‐Ming Wang, Bin Zhang, Xia Yang et al. · Molecular Systems Biology · 2012 · 136 citations · Full text

Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors

David R. McGivern, Takahiro Masaki, Sara E. Williford et al. · Gastroenterology · 2014 · 107 citations · Full text

Biochemistry, Viral Hepatitis, Medicine +10

The Structural Basis for the Selectivity of Benzotriazole Inhibitors of PTP1B

Giovanna Scapin, Sangita B. Patel, Joseph W. Becker et al. · Biochemistry · 2003 · 104 citations · Full text

Drug Target, Selective Ptp1b Inhibitors, Molecular Biology +19

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

Bernard Côté, Jason D. Burch, Ernest Asante‐Appiah et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 97 citations

Medicine, Antiviral Drug Development, Antiviral Therapy +11